one day, when we least expect it you will be right, but for $50 they will need progress on the pipeline compounds. IMGN is very close to a new 52-week high thanks mostly to ONXX and market strength. We will need some strong sales numbers, or pipeline progress, or another big oncology deal, maybe SGEN, or ECYT to really break out to $20+. I would not want to be short here.
I agree, but on the pure technicals, this is set to take off!
The nice thing about IMGN is they have lots of things in the pipeline and their major associations with the big biotech's. If everything gets approved, then we are looking to $200+.
NOW is the time to buy!